Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer (Q27009306)

C. Bethan Powell

2

1 reference

Lee-may Chen

3

1 reference

Jeanne Carter

4

1 reference

Victoria L. Bae Jump

5

1 reference

Lynn P. Parker

6

1 reference

Mark E. Borowsky

7

1 reference

Randall K. Gibb

8

1 reference

language of work or name

1 reference

1 July 2015

1 reference

1 reference

121

1 reference

PubMed

issue

13

1 reference

PubMed

page(s)

2108-20

1 reference

Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Effect of Screening on Ovarian Cancer Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Symptoms associated with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

How are symptoms of ovarian cancer managed? A study of primary care physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Tubal ligation and the risk of ovarian cancer: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The genesis and evolution of high-grade serous ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The preclinical natural history of serous ovarian cancer: defining the target for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The fallopian tube: primary site of most pelvic high-grade serous carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The post-reproductive Fallopian tube: better removed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Underlying mechanisms of ovarian cancer risk reduction after tubal ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Microenvironment and pathogenesis of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Precursors and pathogenesis of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Histologic transformation of benign endometriosis to early epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Hereditary ovarian cancer: beyond the usual suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Pathologic findings in prophylactic oophorectomy specimens in high-risk women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Ovarian Cancer Is an Imported Disease: Fact or Fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

21 January 2018

Cancer risk and PCOS.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Clomiphene citrate causes aberrant tubal apoptosis and estrogen receptor activation in rat fallopian tube: implications for tubal ectopic pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Association between hysterectomy with ovarian preservation and cardiovascular disease in a Norwegian population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Fracture risk after bilateral oophorectomy in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Ovarian function before and after salpingectomy in artificial reproductive technology patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Prophylactic salpingectomy does not impair the ovarian response in IVF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Impaired ovarian blood flow and reduced antral follicle count following laparoscopic salpingectomy for ectopic pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

A breast reconstruction needs assessment: How does self-efficacy affect information access and preferences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

The forgotten fallopian tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Epithelial Abnormalities in Cystic Ovarian Endometriosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Ovarian tumors associated with atypical endometriosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Primary carcinoma of the fallopian tube

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Tubal ligation and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29321

7 January 2021

Identifiers

DOI

10.1002/CNCR.29321

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25820366

1 reference

Consolidated OpenCitations Corpus – April 2017